The World Anti-Doping Agency (WADA) has provisionally suspended the accreditation of the laboratory in Châtenay-Malabry, near Paris. The laboratory, run by the French anti-doping agency AFLD, developed the urine test for EPO and carries out much of the analysis of samples taken at the Tour de France.
In a statement issued on Monday evening, WADA announced that the provisional suspension had been handed down “due to analytical issues self-reported to WADA by the Laboratory".
The suspension took effect on September 24 and prohibits the laboratory from analysing urine and blood samples pending a hearing of WADA’s independent disciplinary committee.
Le Monde has reported that there were two instances of contamination in the laboratory, which arose after a urine sample with an exceptionally high concentration of anabolic steroids had left a residue on the testing equipment that remained even after thorough washing.
According to Le Monde, the Châtenay-Malabry lab found traces of steroids in two urine samples in the spring but, following a request for the analysis of the B sample, it was established on August 25 that the samples had been contaminated by the testing equipment.
The AFLD reported the error to WADA on August 28, and had hoped to escape a complete shutdown of its operations.
You can read more at Cyclingnews.com
via Cyclingnews Latest News http://ift.tt/2wXqGpO
No comments:
Post a Comment